Follow
Oguzhan Alagoz
Title
Cited by
Cited by
Year
State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3
U Siebert, O Alagoz, AM Bayoumi, B Jahn, DK Owens, DJ Cohen, ...
Medical Decision Making 32 (5), 690-700, 2012
8492012
Markov decision processes: a tool for sequential decision making under uncertainty
O Alagoz, H Hsu, AJ Schaefer, MS Roberts
Medical Decision Making 30 (4), 474-483, 2010
3672010
Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012
SK Plevritis, D Munoz, AW Kurian, NK Stout, O Alagoz, AM Near, SJ Lee, ...
Jama 319 (2), 154-164, 2018
3362018
Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies
JS Mandelblatt, NK Stout, CB Schechter, JJ Van Den Broek, DL Miglioretti, ...
Annals of internal medicine 164 (4), 215-225, 2016
3222016
The optimal timing of living-donor liver transplantation
O Alagoz, LM Maillart, AJ Schaefer, MS Roberts
Management Science 50 (10), 1420-1430, 2004
3122004
Modeling secrecy and deception in a multiple-period attacker–defender signaling game
J Zhuang, VM Bier, O Alagoz
European Journal of Operational Research 203 (2), 409-418, 2010
2842010
OR Forum—A POMDP approach to personalize mammography screening decisions
T Ayer, O Alagoz, NK Stout
Operations Research 60 (5), 1019-1034, 2012
2682012
Comparison of logistic regression and artificial neural network models in breast cancer risk estimation
T Ayer, J Chhatwal, O Alagoz, CE Kahn Jr, RW Woods, ES Burnside
Radiographics 30 (1), 13-22, 2010
2592010
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts
BL Sprague, NK Stout, C Schechter, NT Van Ravesteyn, M Cevik, ...
Annals of internal medicine 162 (3), 157-166, 2015
2522015
Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration
T Ayer, O Alagoz, J Chhatwal, JW Shavlik, CE Kahn Jr, ES Burnside
Cancer 116 (14), 3310-3321, 2010
2262010
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality
D Munoz, AM Near, NT Van Ravesteyn, SJ Lee, CB Schechter, O Alagoz, ...
Journal of the National Cancer Institute 106 (11), dju289, 2014
1912014
Determining the acceptance of cadaveric livers using an implicit model of the waiting list
O Alagoz, LM Maillart, AJ Schaefer, MS Roberts
Operations Research 55 (1), 24-36, 2007
1872007
Optimal breast biopsy decision-making based on mammographic features and demographic factors
J Chhatwal, O Alagoz, ES Burnside
Operations research 58 (6), 1577-1591, 2010
1712010
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography
NK Stout, SJ Lee, CB Schechter, K Kerlikowske, O Alagoz, D Berry, ...
Journal of the National Cancer Institute 106 (6), dju092, 2014
1682014
Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling
O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ...
JNCI: Journal of the National Cancer Institute 113 (11), 1484-1494, 2021
1592021
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk
NT Van Ravesteyn, DL Miglioretti, NK Stout, SJ Lee, CB Schechter, ...
Annals of internal medicine 156 (9), 609-617, 2012
1562012
A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process
SM Shechter, CL Bryce, O Alagoz, JE Kreke, JE Stahl, AJ Schaefer, ...
Medical Decision Making 25 (2), 199-209, 2005
1522005
A survey of optimization models on cancer chemotherapy treatment planning
J Shi, O Alagoz, FS Erenay, Q Su
Annals of Operations Research 221, 331-356, 2014
1462014
Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts
CI Lee, M Cevik, O Alagoz, BL Sprague, ANA Tosteson, DL Miglioretti, ...
Radiology 274 (3), 772-780, 2015
1402015
Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes
A Trentham-Dietz, K Kerlikowske, NK Stout, DL Miglioretti, CB Schechter, ...
Annals of internal medicine 165 (10), 700-712, 2016
1312016
The system can't perform the operation now. Try again later.
Articles 1–20